Advertisement

Picture Kentro Design Corporate and Web Design for Start Ups 2x 650x80px
Organisation › Details

Bit Bio Ltd. (bit.bio)

Accelerated biomedical research, new generations of cures, increased global sustainability. These are in reach when biology transitions to engineering. At bit.bio, we work relentlessly to achieve this goal. We combine the concepts of coding and biology to provide human cells for research, drug discovery and cell therapy, enabling a new generation of medicines. Key facts bit.bio was founded in 2016 by Dr Mark Kotter from his labs at Cambridge University after his discovery of the opti-ox™ technology. Co-founder Florian Schuster joined in 2018 as the company continued to grow and develop. The company now has over 130 employees and is headquartered in Cambridge, UK and San Francisco, US. In July 2019, the company announced the closure of a $41.5m Series A fundraise. The company recently expanded its board to include: > Dr Hermann Hauser, serial entrepreneur, co-founder of Amadeus Capital Partners and founder of semiconductor company, Arm Ltd, and gene-sequencing company, Solexa / Illumina, joins as chair of the board. > Sir Greg Winter, Nobel-winning scientist, and known for his work on monoclonal antibodies, is the founder of multiple successful biotech companies. > Alan S. Roemer, biotechnology entrepreneur who launched Pharmasset and Roivant Sciences, has raised over $1.75 billion in private and public capital and consummated five IPOs *

 

Period Start 2019-10-15 renamed
  Predecessor Elpis BioMed Ltd.
Products Industry opti-ox™ cell reprogramming platform (optimised, inducible over-expression)
  Industry 2 cell research product
Persons Person Kotter, Mark (Elpis BioMed 2017– CEO + Founder)
  Person 2 Milner, Jonathan (Abcam 201409 Deputy Chairman + largest shareholder before CEO + Co-founder)
     
Region Region Cambridge, Cambridgeshire
  Country United Kingdom (GB)
  Street Discovery Drive
Cambridge Biomedical Campus
  City CB2 0AX Cambridge, Cambridgeshire
    Address record changed: 2021-01-29
     
Basic data Employees D: 101 to 500 (2021-11-05)
     
    * Document for �About Section�: Bit Bio Ltd.. (11/5/21). "Press Release: bit.bio Raises $103 Million in First Close of Series B Financing". Cambridge.
     
   
Record changed: 2021-11-06

Advertisement

Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x200px

More documents for Bit Bio Ltd. (bit.bio)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x300px




» top